Osteoimmunology: Crosstalk between the immune and bone systems

Journal of Clinical Immunology

Volumn 29, Issue 5, 2009, Pages 555-567

  Nakashima, Tomoki ^a   Takayanagi, Hiroshi ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Bone destruction; NFATc1; Osteoclast; RANKL; TH17

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; CYCLOSPORIN A; CYTOKINE; FINGOLIMOD; LEFLUNOMIDE; METHOTREXATE; NUCLEAR FACTOR OF ACTIVATED T CELL CYTOPLASMIC 1; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; SALAZOSULFAPYRIDINE; TACROLIMUS; TRANSCRIPTION FACTOR NFAT; UNCLASSIFIED DRUG;

ALBERS SCHOENBERG DISEASE; ARTHRITIS; ARTICLE; BONE DESTRUCTION; BONE DEVELOPMENT; BONE METABOLISM; CALCIUM SIGNALING; GENE MUTATION; HUMAN; IMMUNE RESPONSE; IMMUNOREGULATION; NONHUMAN; OSTEOCLAST; OSTEOCLASTOGENESIS; PHENOTYPE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SKELETON; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; TH17 CELL;

ANIMALS; ARTHRITIS, RHEUMATOID; BONE AND BONES; HUMANS; IMMUNE SYSTEM; INTERLEUKIN-17; LYMPHOCYTE ACTIVATION; MICE; NFATC TRANSCRIPTION FACTORS; OSTEOGENESIS; POLYMORPHISM, GENETIC; RANK LIGAND; RECEPTOR CROSS-TALK; SIGNAL TRANSDUCTION; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 69249229479     PISSN: 02719142     EISSN: 15732592     Source Type: Journal    
DOI: 10.1007/s10875-009-9316-6     Document Type: Article

References (130)

1. H Takayanagi 2007 Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems Nat Rev Immunol 7 292 304
2. LE Theill WJ Boyle JM Penninger 2002 RANK-L and RANK: T cells, bone loss, and mammalian evolution Annu Rev Immunol 20 795 823
3. G Karsenty EF Wagner 2002 Reaching a genetic and molecular understanding of skeletal development Dev Cell 2 389 406
4. MC Walsh N Kim Y Kadono J Rho SY Lee J Lorenzo, et al. 2006 Osteoimmunology: interplay between the immune system and bone metabolism Annu Rev Immunol 24 33 63
5. JE Horton LG Raisz HA Simmons JJ Oppenheim SE Mergenhagen 1972 Bone resorbing activity in supernatant fluid from cultured human peripheral blood leukocytes Science 177 793 795
6. M Gowen DD Wood EJ Ihrie MK McGuire RG Russell 1983 An interleukin 1 like factor stimulates bone resorption in vitro Nature 306 378 380 (Pubitemid 14242749)
7. FE Dewhirst PP Stashenko JE Mole T Tsurumachi 1985 Purification and partial sequence of human osteoclast-activating factor: identity with interleukin 1 β J Immunol 135 2562 2568
8. N Takahashi T Akatsu N Udagawa T Sasaki A Yamaguchi JM Moseley, et al. 1988 Osteoblastic cells are involved in osteoclast formation Endocrinology 123 2600 2602
9. N Takahashi H Yamana S Yoshiki GD Roodman GR Mundy SJ Jones, et al. 1988 Osteoclast-like cell formation and its regulation by osteotropic hormones in mouse bone marrow cultures Endocrinology 122 1373 1382
10. T Suda N Takahashi N Udagawa E Jimi MT Gillespie TJ Martin 1999 Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families Endocr Rev 20 345 357 (Pubitemid 30649812)
11. WS Simonet DL Lacey CR Dunstan M Kelley MS Chang R Luthy, et al. 1997 Osteoprotegerin: a novel secreted protein involved in the regulation of bone density Cell 89 309 319
12. H Yasuda N Shima N Nakagawa SI Mochizuki K Yano N Fujise, et al. 1998 Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro Endocrinology 139 1329 1337
13. DL Lacey E Timms HL Tan MJ Kelley CR Dunstan T Burgess, et al. 1998 Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation Cell 93 165 176
14. H Yasuda N Shima N Nakagawa K Yamaguchi M Kinosaki S Mochizuki, et al. 1998 Osteoclast differentiation factor is a ligand for osteoprotegerin/ osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL Proc Natl Acad Sci U S A 95 3597 3602
15. DM Anderson E Maraskovsky WL Billingsley WC Dougall ME Tometsko ER Roux, et al. 1997 A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function Nature 390 175 179
16. BR Wong J Rho J Arron E Robinson J Orlinick M Chao, et al. 1997 TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells J Biol Chem 272 25190 25194
17. E Tsuda M Goto S Mochizuki K Yano F Kobayashi T Morinaga, et al. 1997 Isolation of a novel cytokine from human fibroblasts that specifically inhibits osteoclastogenesis Biochem Biophys Res Commun 234 137 142
18. YY Kong H Yoshida I Sarosi HL Tan E Timms C Capparelli, et al. 1999 OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis Nature 397 315 323
19. N Kim PR Odgren DK Kim SC Marks Jr Y Choi 2000 Diverse roles of the tumor necrosis factor family member TRANCE in skeletal physiology revealed by TRANCE deficiency and partial rescue by a lymphocyte-expressed TRANCE transgene Proc Natl Acad Sci U S A 97 10905 10910
20. WC Dougall M Glaccum K Charrier K Rohrbach K Brasel T De Smedt, et al. 1999 RANK is essential for osteoclast and lymph node development Genes Dev 13 2412 2424
21. J Li I Sarosi XQ Yan S Morony C Capparelli HL Tan, et al. 2000 RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism Proc Natl Acad Sci U S A 97 1566 1571
22. N Bucay I Sarosi CR Dunstan S Morony J Tarpley C Capparelli, et al. 1998 osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification Genes Dev 12 1260 1268
23. A Mizuno N Amizuka K Irie A Murakami N Fujise T Kanno, et al. 1998 Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor/ osteoprotegerin Biochem Biophys Res Commun 247 610 615
24. C Sobacchi A Frattini MM Guerrini M Abinun A Pangrazio L Susani, et al. 2007 Osteoclast-poor human osteopetrosis due to mutations in the gene encoding RANKL Nat Genet 39 960 962
25. AE Hughes SH Ralston J Marken C Bell H MacPherson RG Wallace, et al. 2000 Mutations in TNFRSF11A, affecting the signal peptide of RANK, cause familial expansile osteolysis Nat Genet 24 45 48
26. MP Whyte SE Obrecht PM Finnegan JL Jones MN Podgornik WH McAlister, et al. 2002 Osteoprotegerin deficiency and juvenile Paget's disease N Engl J Med 347 175 184
27. MM Guerrini C Sobacchi B Cassani M Abinun SS Kilic A Pangrazio, et al. 2008 Human osteoclast-poor osteopetrosis with hypogammaglobulinemia due to TNFRSF11A (RANK) mutations Am J Hum Genet 83 64 76
28. MP Whyte 2006 Paget's disease of bone and genetic disorders of RANKL/OPG/RANK/NF-κB signaling Ann N Y Acad Sci 1068 143 164
29. T Nakashima Y Kobayashi S Yamasaki A Kawakami K Eguchi H Sasaki, et al. 2000 Protein expression and functional difference of membrane-bound and soluble receptor activator of NF-κB ligand: modulation of the expression by osteotropic factors and cytokines Biochem Biophys Res Commun 275 768 775
30. J Schlondorff L Lum CP Blobel 2001 Biochemical and pharmacological criteria define two shedding activities for TRANCE/OPGL that are distinct from the tumor necrosis factor alpha convertase J Biol Chem 276 14665 14674
31. T Miyamoto F Arai O Ohneda K Takagi DM Anderson T Suda 2000 An adherent condition is required for formation of multinuclear osteoclasts in the presence of macrophage colony-stimulating factor and receptor activator of nuclear factor κB ligand Blood 96 4335 4343
32. A Hikita I Yana H Wakeyama M Nakamura Y Kadono Y Oshima, et al. 2006 Negative regulation of osteoclastogenesis by ectodomain shedding of receptor activator of NF-κB ligand J Biol Chem 281 36846 36855
33. DH Jones T Nakashima OH Sanchez I Kozieradzki SV Komarova I Sarosi, et al. 2006 Regulation of cancer cell migration and bone metastasis by RANKL Nature 440 692 696
34. E Jimi S Akiyama T Tsurukai N Okahashi K Kobayashi N Udagawa, et al. 1999 Osteoclast differentiation factor acts as a multifunctional regulator in murine osteoclast differentiation and function J Immunol 163 434 442 (Pubitemid 29295871)
35. D Kim RE Mebius JD MacMicking S Jung T Cupedo Y Castellanos, et al. 2000 Regulation of peripheral lymph node genesis by the tumor necrosis factor family member TRANCE J Exp Med 192 1467 1478
36. MR McClung EM Lewiecki SB Cohen MA Bolognese GC Woodson AH Moffett, et al. 2006 Denosumab in postmenopausal women with low bone mineral density N Engl J Med 354 821 831
37. MF Bachmann BR Wong R Josien RM Steinman A Oxenius Y Choi 1999 TRANCE, a tumor necrosis factor family member critical for CD40 ligand-independent T helper cell activation J Exp Med 189 1025 1031
38. AR Moschen A Kaser B Enrich O Ludwiczek M Gabriel P Obrist, et al. 2005 The RANKL/OPG system is activated in inflammatory bowel disease and relates to the state of bone loss Gut 54 479 487
39. AJ Ashcroft SM Cruickshank PI Croucher MJ Perry S Rollinson JM Lippitt, et al. 2003 Colonic dendritic cells, intestinal inflammation, and T cell-mediated bone destruction are modulated by recombinant osteoprotegerin Immunity 19 849 861
40. K Loser A Mehling S Loeser J Apelt A Kuhn S Grabbe, et al. 2006 Epidermal RANKL controls regulatory T-cell numbers via activation of dendritic cells Nat Med 12 1372 1379
41. - inducer cells regulate development of Aire-expressing epithelial cells in the thymic medulla J Exp Med 204 1267 1272
42. T Akiyama Y Shimo H Yanai J Qin D Ohshima Y Maruyama, et al. 2008 The tumor necrosis factor family receptors RANK and CD40 cooperatively establish the thymic medullary microenvironment and self-tolerance Immunity 29 423 437
43. Y Hikosaka T Nitta I Ohigashi K Yano N Ishimaru Y Hayashi, et al. 2008 The cytokine RANKL produced by positively selected thymocytes fosters medullary thymic epithelial cells that express autoimmune regulator Immunity 29 438 450
44. MA Lomaga WC Yeh I Sarosi GS Duncan C Furlonger A Ho, et al. 1999 TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling Genes Dev 13 1015 1024
45. A Naito S Azuma S Tanaka T Miyazaki S Takaki K Takatsu, et al. 1999 Severe osteopetrosis, defective interleukin-1 signalling and lymph node organogenesis in TRAF6-deficient mice Genes Cells 4 353 362
46. BR Wong D Besser N Kim JR Arron M Vologodskaia H Hanafusa, et al. 1999 TRANCE, a TNF family member, activates Akt/PKB through a signaling complex involving TRAF6 and c-Src Mol Cell 4 1041 1049
47. N Kobayashi Y Kadono A Naito K Matsumoto T Yamamoto S Tanaka, et al. 2001 Segregation of TRAF6-mediated signaling pathways clarifies its role in osteoclastogenesis EMBO J 20 1271 1280
48. G Franzoso L Carlson L Xing L Poljak EW Shores KD Brown, et al. 1997 Requirement for NF-κB in osteoclast and B-cell development Genes Dev 11 3482 3496
49. V Iotsova J Caamano J Loy Y Yang A Lewin R Bravo 1997 Osteopetrosis in mice lacking NF-κB1 and NF-κB2 Nat Med 3 1285 1289
50. MG Ruocco S Maeda JM Park T Lawrence LC Hsu Y Cao, et al. 2005 IκB kinase (IKK)β, but not IKKα, is a critical mediator of osteoclast survival and is required for inflammation-induced bone loss J Exp Med 201 1677 1687
51. R Doffinger A Smahi C Bessia F Geissmann J Feinberg A Durandy, et al. 2001 X-linked anhidrotic ectodermal dysplasia with immunodeficiency is caused by impaired NF-κB signaling Nat Genet 27 277 285
52. J Gohda T Akiyama T Koga H Takayanagi S Tanaka J Inoue 2005 RANK-mediated amplification of TRAF6 signaling leads to NFATc1 induction during osteoclastogenesis EMBO J 24 790 799
53. T Wada T Nakashima AJ Oliveira-dos-Santos J Gasser H Hara G Schett, et al. 2005 The molecular scaffold Gab2 is a crucial component of RANK signaling and osteoclastogenesis Nat Med 11 394 399
54. S Bai H Kitaura H Zhao J Chen JM Muller R Schule, et al. 2005 FHL2 inhibits the activated osteoclast in a TRAF6-dependent manner J Clin Invest 115 2742 2751
55. W Jin M Chang EM Paul G Babu AJ Lee W Reiley, et al. 2008 Deubiquitinating enzyme CYLD negatively regulates RANK signaling and osteoclastogenesis in mice J Clin Invest 118 1858 1866
56. EF Wagner R Eferl 2005 Fos/AP-1 proteins in bone and the immune system Immunol Rev 208 126 140
57. K Sato A Suematsu T Nakashima S Takemoto-Kimura K Aoki Y Morishita, et al. 2006 Regulation of osteoclast differentiation and function by the CaMK-CREB pathway Nat Med 12 1410 1416
58. T Yamashita Z Yao F Li Q Zhang IR Badell EM Schwarz, et al. 2007 NF-κB p50 and p52 regulate receptor activator of NF-κB ligand (RANKL) and tumor necrosis factor-induced osteoclast precursor differentiation by activating c-Fos and NFATc1 J Biol Chem 282 18245 18253
59. R Faccio S Takeshita A Zallone FP Ross SL Teitelbaum 2003 c-Fms and the αvβ3 integrin collaborate during osteoclast differentiation J Clin Invest 111 749 758
60. Y Wan LW Chong RM Evans 2007 PPAR-γ regulates osteoclastogenesis in mice Nat Med 13 1496 1503
61. KA Ishii T Fumoto K Iwai S Takeshita M Ito N Shimohata, et al. 2009 Coordination of PGC-1β and iron uptake in mitochondrial biogenesis and osteoclast activation Nat Med 15 259 266
62. H Takayanagi S Kim T Koga H Nishina M Isshiki H Yoshida, et al. 2002 Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling for terminal differentiation of osteoclasts Dev Cell 3 889 901
63. GR Crabtree EN Olson 2002 NFAT signaling: choreographing the social lives of cells Cell 109 Suppl S67 79
64. PG Hogan L Chen J Nardone A Rao 2003 Transcriptional regulation by calcium, calcineurin, and NFAT Genes Dev 17 2205 2232
65. M Asagiri K Sato T Usami S Ochi H Nishina H Yoshida, et al. 2005 Autoamplification of NFATc1 expression determines its essential role in bone homeostasis J Exp Med 202 1261 1269
66. MM Winslow M Pan M Starbuck EM Gallo L Deng G Karsenty, et al. 2006 Calcineurin/NFAT signaling in osteoblasts regulates bone mass Dev Cell 10 771 782
67. AO Aliprantis Y Ueki R Sulyanto A Park KS Sigrist SM Sharma, et al. 2008 NFATc1 in mice represses osteoprotegerin during osteoclastogenesis and dissociates systemic osteopenia from inflammation in cherubism J Clin Invest 118 3775 3789
68. K Matsuo DL Galson C Zhao L Peng C Laplace KZ Wang, et al. 2004 Nuclear factor of activated T-cells (NFAT) rescues osteoclastogenesis in precursors lacking c-Fos J Biol Chem 279 26475 26480
69. SH Lee J Rho D Jeong JY Sul T Kim N Kim, et al. 2006 v-ATPase V0 subunit d2-deficient mice exhibit impaired osteoclast fusion and increased bone formation Nat Med 12 1403 1409
70. M Yagi T Miyamoto Y Sawatani K Iwamoto N Hosogane N Fujita, et al. 2005 DC-STAMP is essential for cell-cell fusion in osteoclasts and foreign body giant cells J Exp Med 202 345 351
71. K Kim SH Lee J Ha Kim Y Choi N Kim 2008 NFATc1 induces osteoclast fusion via up-regulation of Atp6v0d2 and the dendritic cell-specific transmembrane protein (DC-STAMP) Mol Endocrinol 22 176 185
72. SV Komarova A Pereverzev JW Shum SM Sims SJ Dixon 2005 Convergent signaling by acidosis and receptor activator of NF-κB ligand (RANKL) on the calcium/calcineurin/NFAT pathway in osteoclasts Proc Natl Acad Sci U S A 102 2643 2648
73. T Koga M Inui K Inoue S Kim A Suematsu E Kobayashi, et al. 2004 Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis Nature 428 758 763
74. W Zou JL Reeve Y Liu SL Teitelbaum FP Ross 2008 DAP12 couples c-Fms activation to the osteoclast cytoskeleton by recruitment of Syk Mol Cell 31 422 431
75. A Mocsai MB Humphrey JA Van Ziffle Y Hu A Burghardt SC Spusta, et al. 2004 The immunomodulatory adapter proteins DAP12 and Fc receptor γ-chain (FcRγ) regulate development of functional osteoclasts through the Syk tyrosine kinase Proc Natl Acad Sci U S A 101 6158 6163
76. M Shinohara T Koga K Okamoto S Sakaguchi K Arai H Yasuda, et al. 2008 Tyrosine kinases Btk and Tec regulate osteoclast differentiation by linking RANK and ITAM signals Cell 132 794 806
77. i oscillation regulation Genes Dev 21 1803 1816
78. R Masuyama J Vriens T Voets Y Karashima G Owsianik R Vennekens, et al. 2008 TRPV4-mediated calcium influx regulates terminal differentiation of osteoclasts Cell Metab 8 257 265
79. 2+ oscillation-independent NFATc1 activation during osteoclastogenesis Proc Natl Acad Sci U S A 105 8643 8648
80. 2+ oscillation EMBO J 22 3825 3832
81. D Mao H Epple B Uthgenannt DV Novack R Faccio 2006 PLCgamma2 regulates osteoclastogenesis via its interaction with ITAM proteins and GAB2 J Clin Invest 116 2869 2879
82. M Bromley DE Woolley 1984 Chondroclasts and osteoclasts at subchondral sites of erosion in the rheumatoid joint Arthritis Rheum 27 968 975 (Pubitemid 14004758)
83. EM Gravallese Y Harada JT Wang AH Gorn TS Thornhill SR Goldring 1998 Identification of cell types responsible for bone resorption in rheumatoid arthritis and juvenile rheumatoid arthritis Am J Pathol 152 943 951
84. H Takayanagi H Oda S Yamamoto H Kawaguchi S Tanaka T Nishikawa, et al. 1997 A new mechanism of bone destruction in rheumatoid arthritis: synovial fibroblasts induce osteoclastogenesis Biochem Biophys Res Commun 240 279 286
85. H Takayanagi H Iizuka T Juji T Nakagawa A Yamamoto T Miyazaki, et al. 2000 Involvement of receptor activator of nuclear factor κB ligand/osteoclast differentiation factor in osteoclastogenesis from synoviocytes in rheumatoid arthritis Arthritis Rheum 43 259 269
86. YY Kong U Feige I Sarosi B Bolon A Tafuri S Morony, et al. 1999 Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand Nature 402 304 309
87. EM Gravallese C Manning A Tsay A Naito C Pan E Amento, et al. 2000 Synovial tissue in rheumatoid arthritis is a source of osteoclast differentiation factor Arthritis Rheum 43 250 258
88. AR Pettit H Ji D von Stechow R Muller SR Goldring Y Choi, et al. 2001 TRANCE/RANKL knockout mice are protected from bone erosion in a serum transfer model of arthritis Am J Pathol 159 1689 1699
89. K Redlich S Hayer R Ricci JP David M Tohidast-Akrad G Kollias, et al. 2002 Osteoclasts are essential for TNF-α-mediated joint destruction J Clin Invest 110 1419 1427
90. H Takayanagi T Juji T Miyazaki H Iizuka T Takahashi M Isshiki, et al. 1999 Suppression of arthritic bone destruction by adenovirus-mediated csk gene transfer to synoviocytes and osteoclasts J Clin Invest 104 137 146
91. E Lubberts LA Joosten M Chabaud L van Den Bersselaar B Oppers CJ Coenen-De Roo, et al. 2000 IL-4 gene therapy for collagen arthritis suppresses synovial IL-17 and osteoprotegerin ligand and prevents bone erosion J Clin Invest 105 1697 1710
92. NJ Horwood V Kartsogiannis JM Quinn E Romas TJ Martin MT Gillespie 1999 Activated T lymphocytes support osteoclast formation in vitro Biochem Biophys Res Commun 265 144 150
93. H Takayanagi K Ogasawara S Hida T Chiba S Murata K Sato, et al. 2000 T cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-γ Nature 408 600 605
94. GS Firestein NJ Zvaifler 1990 How important are T cells in chronic rheumatoid synovitis? Arthritis Rheum 33 768 773
95. K Sato A Suematsu K Okamoto A Yamaguchi Y Morishita Y Kadono, et al. 2006 Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction J Exp Med 203 2673 2682
96. S Kotake N Udagawa N Takahashi K Matsuzaki K Itoh S Ishiyama, et al. 1999 IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis J Clin Invest 109 1345 1352
97. H-17 cells in relapsing EAE Nat Immunol 8 172 180
98. SS Ousman BH Tomooka JM van Noort EF Wawrousek K O'Conner DA Hafler, et al. 2007 Protective and therapeutic role for αB-crystallin in autoimmune demyelination Nature 448 474 479
99. AJ van Beelen Z Zelinkova EW Taanman-Kueter FJ Muller DW Hommes SA Zaat, et al. 2007 Stimulation of the intracellular bacterial sensor NOD2 programs dendritic cells to promote interleukin-17 production in human memory T cells Immunity 27 660 669
100. CT Weaver LE Harrington PR Mangan M Gavrieli KM Murphy 2006 Th17: an effector CD4 T cell lineage with regulatory T cell ties Immunity 24 677 688
101. Y Iwakura H Ishigame 2006 The IL-23/IL-17 axis in inflammation J Clin Invest 116 1218 1222
102. + T cells Arthritis Res Ther 7 R291 301
103. MM Zaiss R Axmann J Zwerina K Polzer E Guckel A Skapenko, et al. 2007 Treg cells suppress osteoclast formation: a new link between the immune system and bone Arthritis Rheum 56 4104 4112
104. MA Palladino FR Bahjat EA Theodorakis LL Moldawer 2003 Anti-TNF-α therapies: the next generation Nat Rev Drug Discov 2 736 746
105. D Diarra M Stolina K Polzer J Zwerina MS Ominsky D Dwyer, et al. 2007 Dickkopf-1 is a master regulator of joint remodeling Nat Med 13 156 163
106. AE Kearns S Khosla PJ Kostenuik 2008 Receptor activator of nuclear factor κB ligand and osteoprotegerin regulation of bone remodeling in health and disease Endocr Rev 29 155 192
107. JL Luo W Tan JM Ricono O Korchynskyi M Zhang SL Gonias, et al. 2007 Nuclear cytokine-activated IKKα controls prostate cancer metastasis by repressing Maspin Nature 446 690 694
108. H Kim HK Choi JH Shin KH Kim JY Huh SA Lee, et al. 2009 Selective inhibition of RANK blocks osteoclast maturation and function and prevents bone loss in mice J Clin Invest 119 813 825
109. N Nishimoto T Kishimoto 2006 Interleukin 6: from bench to bedside Nat Clin Pract Rheumatol 2 619 626
110. E Jimi K Aoki H Saito F D'Acquisto MJ May I Nakamura, et al. 2004 Selective inhibition of NF-κB blocks osteoclastogenesis and prevents inflammatory bone destruction in vivo Nat Med 10 617 624
111. M Urushibara H Takayanagi T Koga S Kim M Isobe Y Morishita, et al. 2004 The antirheumatic drug leflunomide inhibits osteoclastogenesis by interfering with receptor activator of NF-κB ligand-stimulated induction of nuclear factor of activated T cells c1 Arthritis Rheum 50 794 804
112. A Suematsu Y Tajiri T Nakashima J Taka S Ochi H Oda, et al. 2007 Scientific basis for the efficacy of combined use of antirheumatic drugs against bone destruction in rheumatoid arthritis Mod Rheumatol 17 17 23
113. O Kollet A Dar T Lapidot 2007 The multiple roles of osteoclasts in host defense: bone remodeling and hematopoietic stem cell mobilization Annu Rev Immunol 25 51 69
114. T Nagasawa 2006 Microenvironmental niches in the bone marrow required for B-cell development Nat Rev Immunol 6 107 116
115. O Kollet A Dar S Shivtiel A Kalinkovich K Lapid Y Sztainberg, et al. 2006 Osteoclasts degrade endosteal components and promote mobilization of hematopoietic progenitor cells Nat Med 12 657 664
116. T Mizoguchi A Muto N Udagawa A Arai T Yamashita A Hosoya, et al. 2009 Identification of cell cycle-arrested quiescent osteoclast precursors in vivo J Cell Biol 184 541 554
117. M Ishii JG Egen F Klauschen M Meier-Schellersheim Y Saeki J Vacher, et al. 2009 Sphingosine-1-phosphate mobilizes osteoclast precursors and regulates bone homeostasis Nature 458 524 528
118. M Asagiri T Hirai T Kunigami S Kamano HJ Gober K Okamoto, et al. 2008 Cathepsin K-dependent toll-like receptor 9 signaling revealed in experimental arthritis Science 319 624 627
119. JE Fata YY Kong J Li T Sasaki J Irie-Sasaki RA Moorehead, et al. 2000 The osteoclast differentiation factor osteoprotegerin-ligand is essential for mammary gland development Cell 103 41 50
120. A Mizuno T Kanno M Hoshi O Shibata K Yano N Fujise, et al. 2002 Transgenic mice overexpressing soluble osteoclast differentiation factor (sODF) exhibit severe osteoporosis J Bone Miner Metab 20 337 344
121. hi osteoclast precursors but is essential for mature osteoclast formation in TNFα-mediated inflammatory arthritis J Bone Miner Res 19 207 213
122. E Gonzalez-Suarez D Branstetter A Armstrong H Dinh H Blumberg WC Dougall 2007 RANK overexpression in transgenic mice with mouse mammary tumor virus promoter-controlled RANK increases proliferation and impairs alveolar differentiation in the mammary epithelia and disrupts lumen formation in cultured epithelial acini Mol Cell Biol 27 1442 1454
123. S Kanzaki M Ito Y Takada K Ogawa K Matsuo 2006 Resorption of auditory ossicles and hearing loss in mice lacking osteoprotegerin Bone 39 414 419
124. H Min S Morony I Sarosi CR Dunstan C Capparelli S Scully, et al. 2000 Osteoprotegerin reverses osteoporosis by inhibiting endosteal osteoclasts and prevents vascular calcification by blocking a process resembling osteoclastogenesis J Exp Med 192 463 474
125. L Palenzuela C Vives-Bauza I Fernandez-Cadenas A Meseguer N Font E Sarret, et al. 2002 Familial expansile osteolysis in a large Spanish kindred resulting from an insertion mutation in the TNFRSF11A gene J Med Genet 39 E67
126. TL Johnson-Pais FR Singer HG Bone CT McMurray MF Hansen RJ Leach 2003 Identification of a novel tandem duplication in exon 1 of the TNFRSF11A gene in two unrelated patients with familial expansile osteolysis J Bone Miner Res 18 376 380
127. K Nakatsuka Y Nishizawa SH Ralston 2003 Phenotypic characterization of early onset Paget's disease of bone caused by a 27-bp duplication in the TNFRSF11A gene J Bone Miner Res 18 1381 1385
128. MP Whyte AE Hughes 2002 Expansile skeletal hyperphosphatasia is caused by a 15-base pair tandem duplication in TNFRSF11A encoding RANK and is allelic to familial expansile osteolysis J Bone Miner Res 17 26 29
129. T Cundy M Hegde D Naot B Chong A King R Wallace, et al. 2002 A mutation in the gene TNFRSF11B encoding osteoprotegerin causes an idiopathic hyperphosphatasia phenotype Hum Mol Genet 11 2119 2127
130. B Chong M Hegde M Fawkner S Simonet H Cassinelli M Coker, et al. 2003 Idiopathic hyperphosphatasia and TNFRSF11B mutations: relationships between phenotype and genotype J Bone Miner Res 18 2095 2104